GENEGUT brings together 9 partners from 8 European countries covering the lifecycle from bench to bedside.
Through a patient-centred approach and grown out of the recent Cost Action UNGAP (CA16205), GENEGUT brings together a patient association with renowned researchers, expert clinical scientists, SMEs and large pharma companies with expertise and patented technologies in global proteomics, nanotechnologies, cyclodextrin synthesis, multicellular models, drug delivery systems and production as well as innovation management, stakeholder involvement and science communication.
GENEGUT benefits from the special partnership between the University College Cork’s School of Pharmacy, represented by GENEGUT project coordinator Prof. Caitriona O’Driscoll, and the APC Microbiome Ireland SF1 Research Centre under principal investigator and Consultant Gastroenterologist Prof. Subrata Ghosh. Both research groups share a long history of fruitful collaboration, and a track record of translational research in the field of drug delivery and the treatment of inflammatory bowel disease. This partnership unites pre-clinical and clinical skills and will enable the UCC team to join forces for the development of an RNA-based therapy for ileal CD.
- Dr. Ken Nally
- Dr. Patrick O’Dwyer
Bangor University (BU)
Institute for Research and Innovation in Health (i3S)
Uppsala University (UU)
- Cellular specificity and mechanism
Establish relevant healthy and diseased intestinal cell models
Kinetics and mechanisms of RNA nanoparticle uptake
Intracellular localization and endosomal escape
Janssen Pharmaceutica NV
- Dr. Giustino Di Pretoro
Lonza Capsules & Health Ingredients - Capsugel SAS
- Dr. Remi Fournier
- Dr. Ljilijana Palangetic
- Dr. Stephanie Laurichesse-Ohnimus
European Federation of Crohn's and Ulcerative Colitis Associations
- Mrs. Luisa Avedano
- Mr. Salvo Leone
- Ms. Maria Stellla de Rocchis